Neutral Trial, Positive Spin: PROTECTED TAVR Neutral Trial, Positive Spin: PROTECTED TAVR

The primary endpoint was negative for a trial of embolic protection during transcatheter aortic valve replacement, yet the paper ' s conclusion emphasized the potential benefit.theheart.org on Medscape
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Cardiology Commentary Source Type: news